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Background: Autoimmune neutropenia of infancy (AIN) is a frequent cause of neutropenia 
in children. The disease is caused by antibodies against epitopes on the immunoglobulin 
G (IgG) Fc receptor type 3b (FcγIIIb). We investigated the possible association of human 
neutrophil antigens (HNA), human leukocyte antigen (HLA)- DR, and HLA- DQ alleles with 
AIN and the association of these genotypes with the presence of autoantibodies.
Methods: Eighty AIN cases with a median age of 13.5 months were included. Controls 
were healthy unrelated Danish blood donors. Anti- HNA- 1a autoantibodies were detected 
using a flow cytometric granulocyte immunofluorescence test (Flow- GIFT) with pheno-
typed donor cells for detection of antibody specificity. Molecular determination of HNA 
genotypes was determined using real- time polymerase chain reaction (q- PCR). High- 
resolution HLA- DRB1 and HLA- DQB1 were determined by next- generation sequencing.
Results: Antibodies against HNA- 1a were detected in 51% (n = 41) of AIN patients, 
and anti- HNA- 1b was detected in 3% (n = 2) of cases. In 46% of cases, the anti-
bodies were anti- FcγIIIb- reactive. FCGR3B*01+,*02- ,*03- was more common (odds 
ratio, 6.70; P < .0001), and FCGR3B*01- ,*02+,*03- was less common (odds ratio, 
0.30; P < .0001) among AIN cases. HNA- 1a antibodies were significantly more fre-
quent among AIN cases with the FCGR3B*01+,*02- ,*03- genotype (odds ratio, 3.86; 
P < .007). The HLA- DRB1*14 - HLA- DQB1*05:03 haplotype was significantly more 
common (odds ratio, 7.44; P < .0001) in AIN patients.
Conclusion: The HLA haplotype HLA- DRB1*14 - DQB1*05:03 is associated with Danish 
AIN cases. Among Danish AIN patients, anti- HNA- 1a is the most common autoantibody, 
and the antibody is more common in cases with the FCGR3B*01+,*02- ,*03- genotype.
K E Y W O R D S
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1  | INTRODUC TION
Primary autoimmune neutropenia of infancy (AIN) is a disease in 
which antibodies recognize membrane antigens of neutrophils, 
mostly located on immunoglobulin G (IgG) Fc receptor type 3b 
(FcγRIIIb (CD16b)), causing their peripheral destruction and is a 
frequent type of severe neutropenia in children under 3- 4 years 
of age. Five systems of neutrophil antigens (HNAs) with at least 
11 antigens have to date been described. HNA- 1 (FcγRIIIb) is the 
most immunogenic glycoprotein on the granulocyte membrane 
and has at least four alleles FCGR3B*01 (HNA- 1a), FCGR3B*02 
(HNA- 1b,1d), and FCGR3B*03 (HNA- 1c) which constitute the prin-
cipal antigens implicated in autoimmune neutropenia of infancy 
(AIN). Three other systems, HNA- 3, HNA- 4, and HNA- 5, are bi-
allelic antigens encoded by the choline transporter- like protein- 2 
gene (SLC44A2), the integrin alpha M gene (ITGAM), and the in-
tegrin alpha L (ITGAL) gene, respectively. The complete genetic 
background for the HNA- 2 genotype remains to be elucidated.1 
The disease is often self- limiting, and most patients are in com-
plete remission after 2- 3 years.2 The overall risk of severe inva-
sive bacterial and fungal infections is relatively low with respect 
to the neutrophil count since the bone marrow function is normal.3 
The presentation of antigens to the immune system relies on the 
highly polymorphic human leukocyte antigens (HLAs). Specific 
HLA types are strongly associated with the risk of autoimmune 
diseases.4 This association is often disease- specific and may rep-
resent the superiority of these HLA proteins in binding antigens 
with autoantigenic potential.5 Associations with HLA- DR2 geno-
types6 and the HLA- DRB1*14 and - DQB1*05:03 genotypes7 have 
previously been suggested in AIN. In the present study, we inves-
tigated the association between the HLA- DRB1 and HLA- DQB1 
and HNA- 1, HNA- 3, HNA- 4, and HNA- 5 genotypes and the risk of 
AIN in a cohort of 80 Danish AIN patients. To obtain better insight 
into the relationship between AIN and HNA antibodies, we inves-
tigated the association between HNA genotypes and anti- HNA- 1a 
antibodies, since it has previously been shown that primary AIN is 
more frequent in individuals with the FCGR3B*01 (HNA- 1a) allele.8
2  | METHODS
2.1 | Study cohort
Eighty AIN patients diagnosed between 2005 and 2015 at the 
Department of Clinical Immunology, Aalborg University Hospital, 
Aalborg, Denmark, were included in the study. Inclusion criteria 
were the presence of neutropenia defined as absolute neutrophil 
count (ANC) < 1.5 × 109/L in two repeated tests, age ≤ 5 years, and 
the presence of anti- neutrophil antibodies in the flow cytometric 
indirect granulocyte immunofluorescence test (Flow- GIFT). The 
exclusion criteria were inborn neutropenia, neutropenia related 
to inborn syndromes, post- infection neutropenia, and hematologi-
cal malignancies. Genetic material for HNA and HLA genotyping 
was available from all patients, and consent for study participation 
was obtained from the legal guardian. Antibody specificity was de-
termined from the panel reactivity in the Flow- GIFT. The control 
group consisted of healthy Danish blood donors from the Aalborg 
University Hospital blood bank, Aalborg, Denmark. A group of 200 
randomly selected Danish blood donors were tested for the HNA- 
1, HNA- 3, HNA- 4, and HNA- 5 genotypes. The control group for 
HLA genotyping consisted of 298 randomly selected bone mar-
row donors from the Danish bone marrow registry. Both control 
groups consisted primarily of Caucasians. All samples were han-
dled anonymously. The study was approved by the local ethics 
committee.
2.2 | Samples
Blood samples consisted of EDTA- stabilized whole blood for geno-
typing and blood serum for Flow- GIFT.
2.3 | DNA preparation
DNA was extracted from peripheral blood using the Maxwell16 
Blood DNA Kit on the Maxwell16 Instrument (Promega Corporation).
2.4 | HNA genotyping
Real- time polymerase chain reaction using TaqMan probes was 
used for the genotyping of eight single- nucleotide polymor-
phisms in the HNA- 1 (FCGR3B) (rs447536, rs448740, rs52820103, 
rs428888, and rs2290834), HNA- 3 (SLC44A2) (rs2288904), 
HNA- 4 (ITGAM) (rs1143679), and HNA- 5 (ITGAL) (rs2230433) loci 
as previously described.9 The analysis is ISO accredited (DANAK, 
Denmark) and validated continuously in the IGIW and INSTAND 
programs.
2.5 | High- resolution HLA- DRB1 and  
HLA- DQB1 genotyping
High- resolution HLA typing was performed by next- generation 
sequencing- based HLA typing using the Illumina MiSeq platform 
Key Message
Autoimmune neutropenia of infancy is a common cause 
of severe neutropenia in small children. The genetic back-
ground is still unknown. We report an association with cer-
tain human leukocyte antigens (HLA) and human neutrophil 
antigens (HNA) genotypes and with respect to disease risk.
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at Histogenetics. HLA typing with 2× high resolution at the 4- 
digit allelic level without ambiguities for HLA class II genotyping 
was performed. Exons 2 and 3 were sequenced for HLA class II 
alleles.
2.6 | Flow- GIFT analysis
Briefly, EDTA- stabilized whole blood from HNA phenotyped do-
nors was washed three times in PBS with 5% fetal calf serum. 
Packed cells were incubated for 30 minutes with patient sera at 37 
degrees Celsius, washed twice, and blocked with heat- inactivated 
rabbit serum. After 30 minutes of incubation with polyclonal rab-
bit anti- human IgM and IgG antibodies (DAKO, Denmark), eryth-
rocytes were lysed and the cells were fixed. 100 000 cells were 
analyzed. The samples were analyzed using a BD FACS Canto 
flow cytometer (Becton Dickinson). Flow- GIFT was considered 
positive if mean fluorescent intensity (MFI) ≥2 times the negative 
control using AB serum. For determination of antibody specificity, 
the panel cells always consisted of two HNA- 1aa, two HNA- 1ab, 
and one HNA- 1bb donor. One donor in the panel was selected 
for the subsequent expression of HNA- 1c. The donor cells were 
selected by genotyping and after this, a confirmatory phenotyp-
ing using sera with known specificity. The analysis was performed 
as part of routine clinical practice in an International Society of 
Blood Transfusion (ISBT) reference laboratory. The analysis is ISO 
accredited (DANAK, Denmark) and validated continuously in the 
IGIW and INSTAND programs.
2.7 | Statistical analysis
STATA software (StataCorp) and Excel (Microsoft) were used for 
statistical analysis. The allele frequencies were calculated by direct 
counting. Odds ratios (ORs) and 95% confidence intervals (CIs) were 
calculated, and differences between populations were tested using 
Fischer's exact test. The Bonferroni- corrected significance level was 
used in all analyses.
3  | RESULTS
3.1 | Baseline characteristics
We included 80 children (37 females (46%) and 43 males (54%)) with 
newly diagnosed AIN with a median age at diagnosis of 13.5 months 
(5- 40 months).
3.2 | Neutrophil reactive antibodies
Forty- three samples contained antibodies with conclusive anti- HNA 
specificity. Forty- one samples (51%) had anti- HNA- 1a specificity, 
and 2 samples (3%) had anti- HNA- 1b specificity. Thirty- seven sam-
ples (46%) revealed a broad reactive pattern against the panel cells 
and were concluded to be anti- FcγRIIIb reactive.
3.3 | HNA genotypes and anti- HNA- 1a association
The presence of FCGR3B*01+,*02- ,*03- (OR = 6.70 (3.70- 12.10)) was 
significantly higher in the AIN patient group compared to healthy 
controls, whereas the presence of FCGR3B*01- ,*02+,*03- (OR = 0.30 
(0.14- 0.51)) was decreased in the AIN group compared to healthy 
controls. No other HNA genotypes were significantly associated 
with AIN (Table 1). The presence of anti- HNA- 1a- specific antibodies 
was strongly associated with the presence of the FCGR3B*01+,*02- 
,*03- genotype (OR = 3.86 (1.53- 9.75)) and the absence of the 
FCGR3B*01- ,*02+,*03- genotype (OR = 0.02 (0.01- 0.37)) (Table 3).
3.4 | HLA class II genotypes and anti- HNA- 1a 
association
The distributions of all HLA- DRB1 and HLA- DQB1 alleles are 
reported in supplementary (Tables S1 and S2). HLA- DRB1*14 
(OR = 7.44 (2.83- 19.30)) and HLA- DQB1*05 (OR = 2.50 (1.64- 
3.80)) were significantly associated with AIN, which is well known 
as a DRB1*14- DQB1*05:03 haplotype previously described among 
Caucasian Europeans (OR = 7.44 (2.83- 19.30)) (Table 2). We ob-
served an association between the presence of the HLA- DQ*05:03 
genotype and HNA- 1a- specific antibodies (OR = 2.56 (1.24- 5.24)) 
(Table S4). The HLA- DRB1*14- DQB1*05:03 haplotype was not as-
sociated with antibody specificity (Tables S3 and S4).
4  | DISCUSSION
In the present study, we investigated the possible association be-
tween HLA and HNA genotypes and AIN and discovered an asso-
ciation between HLA- DRB1 and - DQB1 genotypes and risk of AIN. 
We also found association between FCGR3B genotypes and autoan-
tibody specificity.
The mechanism by which HLA antigens are involved in autoim-
mune diseases is still largely unknown;4 however, antigen presenta-
tion and T- cell activation seem to be the key triggering event in most 
autoimmune diseases.10 Association between certain HLA antigens 
and human autoimmune diseases is well established; however, the 
molecular mechanisms underlining this altered self- tolerance remain 
unclear. Proposed mechanisms are viral infections through molecular 
mimicry initiating the activation of autoreactive B cells and CD4 + T 
cells; however, recent research proposes a general deficiency in pe-
ripheral self- tolerance, primarily mediated by an altered function or 
number of regulatory CD4 + T cells.11 Regulatory T cells (Tregs) are 
indeed activated in a HLA restricted manner, and it has been shown 
that certain HLA genotypes can protect or increase susceptibility 
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to a number of autoimmune diseases through a regulatory T cell– 
mediated mechanism. In AIN, a decreased number of circulating 
Tregs have actually been shown by Nakamura et al,12 supporting a 
possible HLA association in this disease. An unknown environmen-
tal factor is thought to trigger this HLA restricted lack of tolerance 
and since autoantibody production continues after the initiating 
environmental trigger is eliminated, epitope spreading is proposed 
as a underlying mechanism13 in antibody- mediated autoimmune 
diseases such as AIN; however, we do not yet know the nature of 
this triggering mechanism in AIN. The FcγRIIIb is polymorphic and 
TA B L E  1   Prevalence of HNA alleles
HNA system Genotype
Patients n = 80 
(%)
Controls n = 200 
(%) OR CI Pa 
HNA- 1 FCGR3B*01+,*02- ,*03- 40 (50.0) 26 (13.0) 6.70 3.70- 12.10 <.0001b
FCGR3B*01+,*02+,*03- 22 (28.0) 78 (39.0) 0.59 0.34- 1.03 .07
FCGR3B*01- ,*02+,*03- 13 (16.0) 84 (42.0) 0.30 0.14- 0.51 <.0001b
FCGR3B*01+,*02- ,*03+ 2 (2.5) 4 (2.0) 1.30 0.24- 5.50 .99
FCGR3B*01+,*02+,*03+ 2 (2.5) 8 (4.0) 0.62 0.13- 2.60 .73
FCGR3B*01- ,*02+,*03+ 1 (1.0) 0 7.566 0.31- 187.70 .082
FCGR3B*01- ,*02- ,*03+ 0 0 *
FCGR3B*01- ,*02- ,*03- 0 0 *
HNA- 3 HNA- 3aa 57 (71.0) 134 (67.0) 0.73 0.73- 2.10 .51
HNA- 3ab 21 (26.0) 58 (29.0) 0.87 0.50- 1.50 .68
HNA- 3bb 2 (3.0) 8 (4.0) 1.67 0.13- 2.39 .75
HNA- 4 HNA- 4aa 65 (81.0) 156 (78.0) 1.30 0.65- 2.32 .63
HNA- 4ab 15 (19.0) 42 (21.0) 1.15 0.47- 1.68 .75
HNA- 4bb 0 2 (1.0) 0.37 0.02- 7.21 1.00
HNA- 5 HNA- 5aa 46 (58.0) 106 (53.0) 1.21 0.72- 2.00 .51
HNA- 5ab 29 (36.0) 78 (39.0) 0.89 0.52- 1.52 .69
HNA- 5bb 5 (6.0) 16 (8.0) 0.76 0.30- 2.11 .80
Abbreviation: n, number of cases.
Significance level after Bonferroni correction to α = 0.05: α/3 = 0.02.
aP- value using Fisher's exact test, bP < .02 
TA B L E  3   Association between HNA genotypes and the presence of anti- HNA- 1a specific
HNA Genotype
Anti- HNA- 1a positive 
n = 41
Anti- HNA- 1a negative 
n = 39 OR 95% CI Pa 
HNA- 1 FCGR3B*01+,*02- ,*03- 27 13 3.86 1.53- 9.75 .007b
FCGR3B*01+,*02+,*03- 12 10 1.20 0.45- 3.21 .80
FCGR3B*01- ,*02+,*03- 0 14 0.02 0.01- 0.37 <.001b
FCGR3B*01+,*02- ,*03+ 1 1 0.95 0.06- 15.74 1.00
FCGR3B*01+,*02+,*03+ 1 1 0.95 0.06- 15.74 1.00
Abbreviation: n, number of cases.
Significance level after Bonferroni correction to α = 0.05: α/3 = 0.02.
aP- value using Fisher's exact test; bP < .02. 
HLA DRB1/DQB1
Patients 
n = 80 (%)
Controls 
n = 298 (%) OR 95% CI P- valuea 
DRB1*14 13 (8.1) 7 (1.2) 7.44 2.83- 19.30 <.0001b
DQB1*05 46 (28.8) 83 (13.9) 2.50 1.64- 3.80 <.0001b
Note: Abbreviation: n, number of cases.
Significance level after Bonferroni correction to α = 0.05: α/13 = 0.004.
aP- value using Fisher's exact test; bP < .004. 
TA B L E  2   Significant HLA- DRB1 and 
HLA- DQB1 alleles
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encodes the HNA- 1 phenotypes known to be associated with AIN. 
Bruin et. al. suggested an association between the HNA- 1a homozy-
gous state encoded by the FCGR3B*01+,*02- ,*03- genotype and the 
risk of AIN.8 Audrain et al. reported similar findings in a French AIN 
cohort.3 Here, we confirmed these findings, and furthermore, we 
discovered that the presence of this FCGR3B variant appears to be 
responsible for all our cases of anti- HNA- 1a- positive AIN. We there-
fore suggest that the FcγRIIIb could play an important role as an au-
toantigen in this disease. Since neutrophils are an essential part of 
the inflammatory process, we speculated whether the combination 
of certain neutrophil antigens, an environmental trigger, and pre-
sentation through some HLA types might explain some cases of this 
disease. Two former smaller studies have explored the association 
between the HLA system and the risk of AIN. Bux et al6 investigated 
26 children using serological HLA typing methods and found an as-
sociation between AIN and the HLA- DR2 phenotype. This finding 
could not be reproduced by Lin et. al., who genotyped 55 AIN pa-
tients and found a strong association with the HLA- DQ*05:03 gen-
otype in Taiwanese children.7 Surprisingly, we discovered the exact 
same association in our cohort of Danish Caucasian patients, sug-
gesting that if an environmental trigger exists, it might be the same 
in these genetically distant populations. These findings even seem 
to be unrelated to the different allele frequencies of the FCGR3B 
gene between these populations.9 Different HLA epitopes bind 
autoantigens differently4 and DQB1*05:03 allele encodes a nega-
tively charged aspartic acid at amino acid position 57 of the b chain, 
replacing positively charged amino acids such as valine, serine, or 
alanine. The peptide binding motif is changed compared to differ-
ent HLA- DQB1*05 genotypes which could explain for the genotype 
effect. When we looked at the association with HLA genotypes and 
the specificity of the autoantibodies, we did not find an associa-
tion (Table S3 and S4). Antibody specificity in AIN can change from 
FcγRIIIb reactivity to anti- HNA- 1a specificity during the disease. 
This finding might suggest that another autoantigen triggers the dis-
ease and the anti- HNA- 1a specificity in some cases is caused by epi-
tope spreading. The HLA- DQ genotypes have also been associated 
with immunization toward food antigens;14 however, no evidence of 
this mechanism has been shown for AIN. Since we are now including 
patients prospectively for the Danish AIN cohort, we hope to update 
these data and hopefully add further information. We also did not 
investigate the binding of antigens to the HLA epitopes associated 
with AIN and this remains a topic for further studies. Today, truly lit-
tle is known about the mechanisms leading to primary autoimmune 
neutropenia. We believe that our study adds further evidence to an 
HLA association with this disease and the possibility of a regulatory 
T cell– mediated mechanism. In conclusion, we report an association 
between certain HNA and HLA antigens and AIN. We support the 
findings from smaller studies and suggest that antigen presentation 
from HLA- DQ phenotypes might be important in solving the etiol-
ogy of AIN.
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